• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·S. Africa·Consumer Cyclical·BRN.JO
Share

Brimstone Investment Corporation Limited Stocks

ZAC 580Last Updated 27.07.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

ZAC 802787.51731

ZAC 580
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Brimstone Investment Corporation Limited, an investment holding firm based in Cape Town, South Africa, was established in 1995. The company maintains a diversified portfolio with interests across various sectors, including food, healthcare, property, Black Economic Empowerment (B-BBEE) initiatives, and enterprise development. Its operational footprint extends beyond South Africa to Australia, Europe, and other international markets. Brimstone's activities encompass commercial fishing for species like cape hakes and king prawns, as well as the processing and distribution of frozen and chilled seafood. Additionally, it operates retail chains such as C2 and Carducci, markets food products under brands like Ladismith Cheese, and delivers advanced solutions to healthcare providers and clinicians throughout Sub-Saharan Africa.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

28.07.2026 19:40

"A Pure Expression of Power": How Christopher Nolan's "Odyssey" Will Change IMAX

28.07.2026 19:12

The Nasdaq 100 has entered a correction phase. The "Wall Street fear" index jumped

28.07.2026 18:30

Southern Japan has been hit by the strongest earthquake in 10 years. TSMC and Sony have factories there.

28.07.2026 17:57

The dollar index has stabilized near a four-week high ahead of the Fed's decision

28.07.2026 17:30

Mercedes has lowered its forecast due to a decline in demand for luxury models. Why did its stock price jump?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026